Skip to main content
. 2023 Feb 7;14:1085041. doi: 10.3389/fendo.2023.1085041

Figure 4.

Figure 4

Molecular mechanisms of HF progression regulated by TMAO. In cardiomyocytes, TMAO activated TGF-β1/Smad3 pathway and increased expression levels of ANP and β-MHC, which caused myocardial hypertrophy and fibrosis; TMAO decreased energy metabolism and mitochondrial function by inhibiting the activity of pyruvate, leading to myocardial damage; TMAO also negatively affected the intracellular Ca2+ processing and myocardial contraction.